Parkwalk EIS University Funds

Parkwalk EIS University Funds

Supports Parkwalk EIS and university founders with strategic innovation funds for early ventures.

Parkwalk Advisors is the UK's most active investor in university spinouts, operating as an EIS fund manager under IP Group plc since 2009. The firm deploys equity capital from Enterprise Investment Scheme (EIS) and Knowledge Intensive EIS (KI-EIS) funds into deeptech companies emerging from UK universities, bridging the gap between academic innovation and commercial markets across three sectors: DeepTech (AI, quantum computing, hardware), HealthTech (digital health, life sciences), and CleanTech (agtech, future mobility). By 2026 Parkwalk had backed more than 200 companies and manages a portfolio of named university-affiliated funds.

Parkwalk operates through dedicated university-partnership funds linked to specific institutions — including Cambridge, Oxford, Imperial College, Bristol, Leeds, Liverpool, Manchester, and Sheffield — alongside flagship EIS funds such as the Opportunities EIS Fund (Series A–C stage, quantum computing, AI, MedTech focus) and Knowledge Intensive EIS Fund V (now closed). Investment stages range from seed through Series C. Ticket sizes span approximately £150,000 at seed to £3,000,000 at later stages, with a median close to £500,000. All capital is deployed as equity; no grants are issued. Eligible companies must typically be TRL 2–5 spinouts with proprietary IP derived from a partner university.

Founders seeking Parkwalk investment apply via the 'Seeking funding?' pathway on the firm's website; the relationship with a relevant university technology transfer office typically facilitates introductions. Co-investment from IP Group plc and other institutional partners is common at larger rounds. Investors into the funds — rather than the spinouts — access UK EIS or KI-EIS tax reliefs, making Parkwalk a route for UK founders to secure both equity capital and connection to a broader institutional co-investment ecosystem.